The bioartificial kidney (Q38165597)

30 August 2017

title

The bioartificial kidney (English)

1 reference

30 August 2017

Deborah A Buffington

1

1 reference

30 August 2017

Angela J Westover

series ordinal

2

1 reference

30 August 2017

Kimberly A Johnston

series ordinal

3

1 reference

30 August 2017

Harvey David Humes

series ordinal

4

1 reference

30 August 2017

publication date

5 November 2013

1 reference

30 August 2017

published in

Translational Research

1 reference

30 August 2017

volume

163

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

342-351

1 reference

Engineering growing tissues

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Tissue engineering and regenerative medicine: concepts for clinical application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Treatment of diabetes by xenogeneic islets without immunosuppression. Use of a vascularized bioartificial pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Stem cell approaches for the treatment of renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

The bioartificial kidney in the treatment of acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Replacement of renal function in uremic animals with a tissue-engineered kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Bioartificial kidney alters cytokine response and hemodynamics in endotoxin-challenged uremic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Renal cell therapy in the treatment of patients with acute and chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Efficacy and safety of renal tubule cell therapy for acute renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Independent association between acute renal failure and mortality following cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

The clinical challenge of cardiorenal syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Acute renal failure and sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Early organogenesis of the kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Ontogeny of hematopoietic cells in Rana pipiens: precursor cell migration during embryogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Ultrastructural study of the teleost fish kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Expression of HLA antigens on renal tubular cells in culture. II. Effect of increased HLA antigen expression on tubular cell stimulation of lymphocyte activation and on their vulnerability to cell-mediated lysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Interleukin 6 production by human proximal tubular epithelial cells in vitro: analysis of the effects of interleukin-1 alpha (IL-1 alpha) and other cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

IL-1 alpha stimulated TNF alpha production by cultured human proximal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Synergistic effect of interleukin-1 and CD40L on the activation of human renal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Production and cytokine-mediated regulation of monocyte chemoattractant protein-1 by human proximal tubular epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Immunologic function and survival in hemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Inflammation enhances cardiovascular risk and mortality in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Kidney protection and regeneration following acute injury: progress through stem cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Stem cell technology for the treatment of acute and chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Mesenchymal stem cells in acute kidney injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Achieving more frequent and longer dialysis for the majority: wearable dialysis and implantable artificial kidney devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Interaction between growth factors and retinoic acid in the induction of kidney tubulogenesis in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Two sets of human-tropic pig retrovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Cryopreservation of complex systems: the missing link in the regenerative medicine supply chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Bioartificial Renal Epithelial Cell System (BRECS): A Compact, Cryopreservable Extracorporeal Renal Replacement Device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Enhanced propagation of adult human renal epithelial progenitor cells to improve cell sourcing for tissue-engineered therapeutic devices for renal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Efficient generation of human T cells from a tissue-engineered thymic organoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Enhanced maintenance and retroviral transduction of primitive hematopoietic progenitor cells using a novel three-dimensional culture system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

The Vicenza wearable artificial kidney for peritoneal dialysis (ViWAK PD).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

A wearable haemodialysis device for patients with end-stage renal failure: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

A wearable hemofilter for continuous ambulatory ultrafiltration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

Toward the wearable artificial kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2013.10.006

10.1016/J.TRSL.2013.10.006

7 January 2021

Identifiers

DOI

1 reference

30 August 2017

1 reference